RNA sequencing of chorionic villi from recurrent pregnancy loss patients reveals impaired function of basic nuclear and cellular machinery

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Sõber, Siim ^a   Rull, Kristiina ^a,b   Reiman, Mario ^a   Ilisson, Piret ^b   Mattila, Pirkko ^c,d   Laan, Maris ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

^c UNIVERSITY OF HELSINKI   (Finland)

^d FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HIST1H1B PROTEIN, HUMAN; HISTONE; MICRORNA; TRANSCRIPTION FACTOR E2F; TRANSCRIPTOME;

BINDING SITE; CELL NUCLEUS; CHORION VILLUS; FEMALE; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; RECURRENT ABORTION; SEQUENCE ANALYSIS;

ABORTION, HABITUAL; BINDING SITES; CELL NUCLEUS; CHORIONIC VILLI; E2F TRANSCRIPTION FACTORS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HISTONES; HUMANS; MICRORNAS; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 85003486031     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep38439     Document Type: Article

References (65)

1. Larsen, E. C., Christiansen, O. B., Kolte, A. M., Macklon, N. New insights into mechanisms behind miscarriage. BMC Med. 11, 154(2013).
2. Christiansen, O. B. Recurrent Pregnancy Loss. (Wiley-Blackwell, 2014).
3. Kolte, A. M., et al. Terminology for pregnancy loss prior to viability: A consensus statement from the ESHRE early pregnancy specialinterest group. Hum. Reprod. 30, 495-498 (2015).
4. Definitions of infertility and recurrent pregnancy loss: A committee opinion. Fertil. Steril. 99, 63 (2013).
5. Jauniaux, E., Farquharson, R. G., Christiansen, O. B., Exalto, N. Evidence-based guidelines for the investigation and medicaltreatment of recurrent miscarriage. Hum. Reprod. 21, 2216-22 (2006).
6. Branch, D. W., Gibson, M., Silver, R. M. Recurrent Miscarriage. N. Engl. J. Med. 363, 1740-1747 (2010).
7. Nagirnaja, L., et al. Structural Genomic Variation as Risk Factor for Idiopathic Recurrent Miscarriage. Hum. Mutat. 35, 972-982(2014).
8. Lund, M., et al. Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success? Obs. Gynecol 119,37-43 (2012).
9. Petriglia, G., et al. Threatened abortion and late-pregnancy complications: A case-control study and review of literature. MinervaGinecol. (2015).
10. Van Oppenraaij, R. H. F., et al. Predicting adverse obstetric outcome after early pregnancy events and complications: A review. Hum. Reprod. Update 15, 409-421 (2009).
11. Krieg, S. A., et al. Global alteration in gene expression profiles of deciduas from women with idiopathic recurrent pregnancy loss. Mol. Hum. Reprod. 18, 442-450 (2012).
12. Rull, K., et al. Increased placental expression and maternal serum levels of apoptosis-inducing TRAIL in recurrent miscarriage. Placenta 34, 141-148 (2013).
13. Wang, Z., Gerstein, M., Snyder, M. RNA-Seq: A revolutionary tool for transcriptomics. Nat. Rev. Genet. 10, 57-63 (2009).
14. Sõber, S., et al. Extensive shift in placental transcriptome profile in preeclampsia and placental origin of adverse pregnancy outcomes. Sci. Rep. 5, 13336 (2015).
15. Morales-Prieto, D. M., Ospina-Prieto, S., Chaiwangyen, W., Schoenleben, M., Markert, U. R. Pregnancy-associated miRNAclusters. J. Reprod. Immunol. 97, 51-61 (2013).
16. Hao, L., et al. The unfolded protein response contributes to preimplantation mouse embryo death in the DDK syndrome. Biol. Reprod. 80, 944-53 (2009).
17. Chai, L., Ling, K., He, X., Yang, R. Expression of ATF4 and VEGF in chorionic villus tissue in early spontaneous abortion. Eur. J. Obstet. Gynecol. Reprod. Biol. 170, 434-438 (2013).
18. Regal, J. F., Gilbert, J. S., Burwick, R. M. The complement system and adverse pregnancy outcomes. Mol. Immunol. 67, 56-70(2015).
19. Sugiura-Ogasawara, M., Nozawa, K., Nakanishi, T., Hattori, Y., Ozaki, Y. Complement as a predictor of further miscarriage incouples with recurrent miscarriages. Hum. Reprod. 21, 2711-2714 (2006).
20. Dória, S., et al. Gene expression pattern of IGF2, PHLDA2, PEG10 and CDKN1C imprinted genes in spontaneous miscarriages orfetal deaths. Epigenetics 5, 444-450 (2010).
21. Khadzhieva, M. B., Lutcenko, N. N., Volodin, I. V., Morozova, K. V., Salnikova, L. E. Association of oxidative stress-related geneswith idiopathic recurrent miscarriage. Free Radic. Res. 48, 534-41 (2014).
22. Gaffuri, B., et al. Unexplained habitual abortion is associated with a reduced endometrial release of soluble intercellular adhesionmolecule-1 in the luteal phase of the cycle. Eur. J. Endocrinol. 142, 477-480 (2000).
23. Mistry, H. D., et al. Differential expression and distribution of placental glutathione peroxidases 1, 3 and 4 in normal andpreeclamptic pregnancy. Placenta 31, 401-408 (2010).
24. Moore, G. E., et al. The role and interaction of imprinted genes in human fetal growth. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 370,20140074 (2015).
25. Janssen, A. B., Tunster, S. J., Heazell, A. E. P., John, R. M. Placental PHLDA2 expression is increased in cases of fetal growthrestriction following reduced fetal movements. BMC Med. Genet. 17, 17 (2016).
26. Tunster, S. J., Creeth, H. D. J., John, R. M. The imprinted Phlda2 gene modulates a major endocrine compartment of the placentato regulate placental demands for maternal resources. Dev. Biol, doi: 10. 1016/j. ydbio. 2015. 10. 015 (2015).
27. Chan, S.-Y., et al. Monocarboxylate Transporter 8 Expression in the Human Placenta: the Effects of Severe Intrauterine GrowthRestriction. J. Endocrinol. 189, 465-471 (2006).
28. Vasilopoulou, E., et al. Differential triiodothyronine responsiveness and transport by human cytotrophoblasts from normal andgrowth-restricted pregnancies. J. Clin. Endocrinol. Metab. 95, 4762-4770 (2010).
29. Eidem, H. R., Ackerman, W. E., McGary, K. L., Abbot, P., Rokas, A. Gestational tissue transcriptomics in term and preterm humanpregnancies: A systematic review and meta-analysis. BMC Med. Genomics 8, 27 (2015).
30. Padovano, V., et al. The POF1B candidate gene for premature ovarian failure regulates epithelial polarity. J. Cell Sci. 124, 3356-3368(2011).
31. The GTEx Consortium. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science(80-. ). 348, 648-660 (2015).
32. Uhlen, M., et al. Tissue-based map of the human proteome. Science (80-. ). 347, 1260419-1260419 (2015).
33. Bione, S., et al. Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B. Hum Reprod 19,2759-2766 (2004).
34. Chen, H.-Z., et al. Canonical and atypical E2Fs regulate the mammalian endocycle. Nat. Cell Biol. 14, 1192-1202 (2012).
35. Ouseph, M. M., et al. Atypical E2F Repressors and Activators Coordinate Placental Development. Dev. Cell 22, 849-862 (2012).
36. Rull, K., Nagirnaja, L., Laan, M. Genetics of recurrent miscarriage: Challenges, current knowledge, future directions. Front. Genet. 3 (2012).
37. Cross, J. C. How to make a placenta: Mechanisms of trophoblast cell differentiation in mice-A Review. Placenta 26 (2005).
38. Kasak, L., Rull, K., Vaas, P., Teesalu, P., Laan, M. Extensive load of somatic CNVs in the human placenta. Sci. Rep. 5, 8342 (2015).
39. Lee, H. O., Davidson, J. M., Duronio, R. J. Endoreplication: Polyploidy with purpose. Genes Dev. 23, 2461-2477 (2009).
40. Weng, L., Zhu, C., Xu, J., Du, W. Critical role of active repression by E2F and Rb proteins in endoreplication during Drosophiladevelopment. EMBO J. 22, 3865-3875 (2003).
41. Dimova, D. K., Dyson, N. J. The E2F transcriptional network: old acquaintances with new faces. Oncogene 24, 2810-2826 (2005).
42. Li, J., et al. Synergistic Function of E2F7 and E2F8 Is Essential for Cell Survival and Embryonic Development. Dev. Cell 14, 62-75(2008).
43. Kohn, M. J., Bronson, R. T., Harlow, E., Dyson, N. J., Yamasaki, L. Dp1 is required for extra-embryonic development. Development130, 1295-1305 (2003).
44. Benevolenskaya, E. V., Frolov, M. V. Emerging links between E2F control and mitochondrial function. Cancer Res. 75, 619-623(2015).
45. Ambrus, A. M., et al. Loss of dE2F Compromises Mitochondrial Function. Dev. Cell 27, 438-451 (2013).
46. Johnson, J., et al. Targeting the RB-E2F pathway in breast cancer. Oncogene 1-7, doi: 10. 1038/onc. 2016. 32 (2016).
47. Schaal, C., Pillai, S., Chellappan, S. P. The Rb-E2F transcriptional regulatory pathway in tumor angiogenesis and metastasis. Adv. Cancer Res. 121, 147-174 (2014).
48. Hollern, D. P., Honeysett, J., Cardiff, R. D., Andrechek, E. R. The E2F Transcription Factors Regulate Tumor Development andMetastasis in a Mouse Model of Metastatic Breast Cancer. Mol. Cell. Biol. 34, 3229-43 (2014).
49. Choi, H. K., et al. Expression of angiogenesis-and apoptosis-related genes in chorionic villi derived from recurrent pregnancy losspatients. Mol. Reprod. Dev. 66, 24-31 (2003).
50. Baek, K.-H. Aberrant gene expression associated with recurrent pregnancy loss. Mol. Hum. Reprod. 10, 291-7 (2004).
51. Lee, J., et al. Differentially expressed genes implicated in unexplained recurrent spontaneous abortion. Int. J. Biochem. Cell Biol. 39,2265-2277 (2007).
52. Rull, K., et al. Increased placental expression and maternal serum levels of apoptosis-inducing TRAIL in recurrent miscarriage. Placenta 34, 141-148 (2013).
53. Kim, D., et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
54. Trapnell, C., et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching duringcell differentiation. Nat. Biotechnol. 28, 511-515 (2010).
55. Anders, S., Pyl, P. T., Huber, W. HTSeq A Python framework to work with high-throughput sequencing data. bioRxiv, doi:10. 1101/002824 (2014).
56. Langmead, B., Trapnell, C., Pop, M., Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to thehuman genome. Genome Biol. 10, R25 (2009).
57. Buermans, H. P. J., Ariyurek, Y., van Ommen, G., den Dunnen, J. T., 't Hoen, P. A. C. New methods for next generation sequencingbased microRNA expression profiling. BMC Genomics 11, 716 (2010).
58. Petitbarat, M., et al. Critical Role and Therapeutic Control of the Lectin Pathway of Complement Activation in an Abortion-ProneMouse Mating. J. Immunol. 195, 5602-5607 (2015).
59. Lee, K. F., et al. Phospholipid transfer protein (PLTP) mRNA expression is stimulated by developing embryos in the oviduct. J. Cell. Biochem. 95, 740-749 (2005).
60. Letavernier, E., et al. Critical role of the calpain/calpastatin balance in acute allograft rejection. Eur. J. Immunol. 41, 473-484 (2011).
61. Murthi, P., et al. GAPDH, 18S rRNA and YWHAZ are Suitable Endogenous Reference Genes for Relative Gene Expression Studiesin Placental Tissues from Human Idiopathic Fetal Growth Restriction. Placenta 29, 798-801 (2008).
62. Anders, S., Huber, W. Differential expression analysis for sequence count data. Genome Biol 11, R106 (2010).
63. Love, M. I., Huber, W., Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. GenomeBiol. 15, 550 (2014).
64. R. Core Team. R: A Language and Environment for Statistical Computing. at (2014).
65. Reimand, J., Kull, M., Peterson, H., Hansen, J., Vilo, J. G:Profiler-a web-based toolset for functional profiling of gene lists fromlarge-scale experiments. Nucleic Acids Res. 35, (2007).